Back to search

Article

Establishment of a RESEARCH USE ONLY Condensed-Efficient-Fast (CEF) PITX2 workflow for analysis of PITX2 DNA methylation in small tumor tissue samples 

2020-01-27

Abstract excerpt

<title>Abstract</title> <p>The CE-marked <italic>therascreen</italic><sup><italic>®</italic></sup> PITX2 RGQ PCR Kit (QIAGEN Cat No./ID 873211), a PITX2 DNA methylation assay was introduced to the market in 2018, (hereinafter referred to as the “standard <italic>therascreen</italic> PITX2 workflow) and represents an <italic>in vitro</italic> diagnostic to predict outcome to anthracycline-based chemotherapy consid...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2a81bd92-513c-585d-9df1-def1d2d5f357
DOI
10.21203/rs.2.20624/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Establishment of a RESEARCH USE ONLY Condensed-Efficient-Fast (CEF) PITX2 workflow for analysis of PITX2 DNA methylation in small tumor tissue samples&nbsp;DOI 10.21203/rs.2.20624/v1
<em>BRAC1</em> & <em>BRCA2</em> Methylation as a Prognostic and Predictive Biomarker in Cancer: Implementation in Liquid Biopsy in the Era of Precision MedicineSemantic proximity
DNA methylation biomarkers for the diagnosis and treatment management of breast cancer: where are we now?Semantic proximity
Νovel methylation biomarkers in liquid biopsy and classifying biosignatures for the clinical management of Breast CancerSemantic proximity
BRCA1 & BRCA2 methylation as a prognostic and predictive biomarker in cancer: Implementation in liquid biopsy in the era of precision medicineSemantic proximity
Single HER2-Positive Tumor Cells are Detected in Initially HER2-Negative Breast Carcinomas using the DEPArray™–HER2-FISH WorkflowSemantic proximity
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.Semantic proximity
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast CancerSemantic proximity
Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patientsSemantic proximity
Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancersSemantic proximity
Development and Clinical Validation of a Real-Time PCR Assay for PITX2 DNA Methylation to Predict Prostate-Specific Antigen Recurrence in Prostate Cancer Patients Following Radical ProstatectomySemantic proximity
Detection of aberrantly methylated tumor suppressor genes in breast cancer patients as a potential diagnostic biomarkerSemantic proximity
Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expression.Semantic proximity
Select a neighboring publication to make it the new centre.